Missed diagnosis of Fabry disease: should we screen patients with multiple sclerosis?

Petra RekovaIvana KovarovaTomas UherBarbora SrpovaGabriela DostalovaAles LinhartManuela VaneckovaDominika Stastna

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2023)

The prevalence of FD in the population of suspected or definite MS patients does not appear to be high. Our results do not support routine FD screening in all patients with a possible diagnosis of MS, but there is an urgent need to search for red flags and include FD in the differential diagnosis of MS.

Keyphrases

mass spectrometry
multiple sclerosis
ms ms
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
risk factors
single cell